InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency
TEL AVIV, Israel, Aug. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that it has …